Pershing Square Foundation invites applications for the MIND Prize

Opened: October 26, 2024
Deadline: November 4, 2024, at 5:00 p.m. ET (Letters of Intent)

The Pershing Square Foundation (PSF) brain initiative funds cutting-edge research that revolutionizes the ability to predict, prevent, and treat neurodegenerative diseases (NDDs). The MIND (Maximizing Innovation in Neuroscience Discovery) Prize supports and empowers early-to-mid-career investigators to rethink conventional paradigms around NDDs. Modeled after the Pershing Square Sohn Prize for Young Investigators in
Cancer Research, the MIND Prize catalyzes interdisciplinary approaches and facilitates collaborations across academic departments and institutions. It fuels the groundbreaking research that will accelerate our understanding of NDDs at every level. 

With these grants, and the scientific and translational research conducted, the Pershing Square Foundation hopes to yield critical tools for and knowledge of NDDs, including Alzheimer’s disease and dementia, which affect millions of people worldwide. Projects may range from the invention of novel tools, techniques, and technologies for mapping and analyzing the brain to bold approaches that demonstrate extraordinary
therapeutic potential. Research domains may include—but are not limited to—neurobiology, brain imaging and mapping, machine learning, drug delivery, and synthetic biology.

Each winner will receive $250,000 per year for three years and become part of a unique network of researchers associated with PSF. Generally, five to seven prizes are awarded annually. Applicants will be notified about the status of their application in early February. Finalist presentations will be held on February 26th, 2025, in New York City. 

For complete information or to view the application, please visit:
https://pershingsquarefoundation.org/portfolio-organization/mind-prize/